Aetna Initiated With Buy By Goldman Sachs

Reinstate Aetna at Buy following Coventry acquisition 
via Goldman Sachs

We have removed the NR designation from Aetna Inc. (NYSE:AET) shares. Aetna is now added to the Buy List with a 12-month price target of $68. Following acquisition of Coventry Health Care, Aetna has greater regional commercial market breadth/strength and is now much better positioned to leverage Medicaid and dual eligible growth opportunities. We also see further upside from Coventry Health Care, Inc. (NYSE:CVH) exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email or click chat button and we will get back to you as quick as humanly possible

Saved Articles

Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers